Scientists at the Montreal Clinical Research Institute (IRCM), led by Université de Montréal medical professor Javier Di Noia ...
Researchers at the University of Osaka have developed a simple culture method that converts B cells isolated from human blood ...
Abogen Biosciences ("Abogen" or the "Group"), a clinical-stage biotechnology group pioneering RNA innovation, announced that it has entered into a licensing and option agreement with Novartis to ...
A team at the National Cancer Institute has unveiled a computational framework that turns ordinary bulk tumor RNA-sequencing ...
Researchers at the University of Osaka have developed a streamlined laboratory method that uses just three sequentially ...
Astrocyte Pharmaceuticals Inc., a pioneering clinical-stage biotechnology company developing first-in-class cerebroprotective ...
A combination treatment for advanced liver cancer appears to do something remarkable inside the tumor itself: it helps build ...
In today's Pharmaceutical Executive Daily, Foghorn Therapeutics and Eli Lilly discontinue development of FHD-909, their oral ...
Cell surface protein labeling supports precise characterization of immune checkpoints, receptors, and other therapeutic ...
On September 15, 2026, GSK plc (“GSK”) announced that it agreed to acquire a trispecific T cell-engager (“TCE”) from Chimagen ...
T cells are not the only attackersWhen people hear about immunotherapy for blood cancers, many may think of CAR-T cell ...
Primary composite endpoint met: 61% of patients achieved visual and pathological response across all treated lesions.Complete clinical and ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results